Functional multidrug resistance in acute myeloblastic leukaemia: A standardized flow cytometric assay for intracellular daunorubicin accumulation

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 194-197

  Pallis, M ^a,b   Russell, N H ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

AML; Daunorubicin; Flow cytometry; Functional mdr

Indexed keywords

DAUNORUBICIN;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE TRANSPORT; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HEALTH CARE QUALITY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTIBIOTICS, ANTINEOPLASTIC; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICROSPHERES;

EID: 0031961960     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00536.x     Document Type: Article

References (9)

1. Broxterman, H.J., Lankelma, J. & Pinedo, H.M. (1996a) How to probe clinical tumor samples for p-glycoprotein and multidrug resistance-associated protein. European Journal of Cancer, 32A, 1024-1035.
2. Broxterman, H.J., Sonneveld, P., Feller, N., Ossenkoppele, G., Wahrer, D.C.R., Eekman, C.A., Schoester, M., Lankelma, J., Pinedo, H.M., Lowenberg, B. & Schuurhuis, G.J. (1996b) Quality control of multidrug resistance assays in adult acute leukaemia: correlation between assays for P-glycoprotein expression and activity. Blood, 87, 4809-4816.
3. Estey, E., Thall, P.F., Andreeff, M., Beran, M., Kanlarjian, H., O'Brien, S., Escudier, S., Robertson, L.E., Koller, C.A., Kornblau, S., Pierce, S., Freireich, E.J., Deisseroth, A. & Keating, M. (1994) Use of granulocyte colony-stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with tludarabine plus cytarabine without granulocyte colony-stimulating factor. Journal of Clinical Oncology, 12, 671-678.
4. Gandler, W. & Shapiro, H. (1990) Logarithmic amplifiers. Cytometry, 11, 447-450.
5. Guerci, A., Merlin, J.L., Missoum, N., Feldmann, L., Marchal, S., Witz, F., Rose, C. & Guerci, O. (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 85, 2147-2153.
6. List, A.F. (1996) Role of multidrug-resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia, 10, 937-942.
7. Marie, J.P., Faussatsuberville, A.M., Zhou, D.C. & Zittoun, R. (1993) Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression. Leukemia, 7, 825-831.
8. Michieli, M., Damiani, D., Ermacora, A., Raspadori, D., Michelutti, A., Grimaz, S., Fanin, R., Russo, D., Lauria, F., Masolini, P. & Baccarani, M. (1997) P-glycoprotein (pgp) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. British Journal of Haematology, 96, 356-365.
9. Paietta, E., Andersen, J., Racevskis, J., Ashigbi, M., Cassileth, P. & Wiernik, P.H. (1995) Modulation of multidrug resistance in de novo adult acute myeloid leukemia: variable efficacy of reverting agents in vitro. Blood Reviews, 9, 47-52.